loadpatents
Patent applications and USPTO patent grants for Huang; Peter Qinhua.The latest application filed is for "nanoparticle formulation of bcl-2 inhibitor".
Patent | Date |
---|---|
Nanoparticle Formulation Of Bcl-2 Inhibitor App 20220273666 - Pinchman; Joseph Robert ;   et al. | 2022-09-01 |
Bcl-2 Protein Inhibitors App 20220265834 - Pinchman; Joseph Robert ;   et al. | 2022-08-25 |
Estrogen Receptor Modulators App 20220235050 - Zhang; Guobao ;   et al. | 2022-07-28 |
Benzamide Compounds App 20220226314 - Pinchman; Joseph Robert ;   et al. | 2022-07-21 |
Benzamide compounds Grant 11,344,546 - Pinchman , et al. May 31, 2 | 2022-05-31 |
Estrogen receptor modulators Grant 11,339,162 - Zhang , et al. May 24, 2 | 2022-05-24 |
Macrocyclic Compounds App 20220144854 - Zhang; Junhu ;   et al. | 2022-05-12 |
Benzamide compounds Grant 11,318,134 - Pinchman , et al. May 3, 2 | 2022-05-03 |
Estrogen Receptor Modulators For Treating Mutants App 20220125769 - Samatar; Ahmed Abdi ;   et al. | 2022-04-28 |
Estrogen receptor modulators for treating mutants Grant 11,278,532 - Samatar , et al. March 22, 2 | 2022-03-22 |
Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones Grant 11,261,192 - Huang , et al. March 1, 2 | 2022-03-01 |
Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones App 20220024939 - Huang; Peter Qinhua ;   et al. | 2022-01-27 |
Egfr Inhibitor Compounds App 20210395230 - Bunker; Kevin Duane ;   et al. | 2021-12-23 |
Estrogen Receptor Modulators App 20210330651 - Huang; Peter Qinhua ;   et al. | 2021-10-28 |
1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one Analogs App 20210317124 - Huang; Peter Qinhua ;   et al. | 2021-10-14 |
L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogs Grant 11,124,518 - Huang , et al. September 21, 2 | 2021-09-21 |
EGFR inhibitor compounds Grant 11,098,030 - Bunker , et al. August 24, 2 | 2021-08-24 |
Estrogen receptor modulators Grant 11,065,233 - Huang , et al. July 20, 2 | 2021-07-20 |
Estrogen receptor modulators Grant 11,065,234 - Huang , et al. July 20, 2 | 2021-07-20 |
Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones App 20210139482 - Huang; Peter Qinhua ;   et al. | 2021-05-13 |
Spirocyclic Compounds App 20210115058 - Huang; Peter Qinhua ;   et al. | 2021-04-22 |
Bicyclic compounds Grant 10,975,035 - Bunker , et al. April 13, 2 | 2021-04-13 |
Acrylic Acid Analogs App 20210094899 - Huang; Peter Qinhua ;   et al. | 2021-04-01 |
Estrogen receptor modulators Grant 10,959,989 - Huang , et al. March 30, 2 | 2021-03-30 |
Spirocyclic compounds Grant 10,934,304 - Huang , et al. March 2, 2 | 2021-03-02 |
Estrogen Receptor Modulators For Treating Mutants App 20210038573 - Samatar; Ahmed Abdi ;   et al. | 2021-02-11 |
Benzamide Compounds App 20210009543 - Pinchman; Joseph Robert ;   et al. | 2021-01-14 |
Benzamide Compounds App 20200338071 - Pinchman; Joseph Robert ;   et al. | 2020-10-29 |
Benzamide Compounds App 20200339605 - Pinchman; Joseph Robert ;   et al. | 2020-10-29 |
Methods for cross coupling Grant 10,793,504 - Pinchman , et al. October 6, 2 | 2020-10-06 |
Spirocyclic Compounds App 20200268714 - Huang; Peter Qinhua ;   et al. | 2020-08-27 |
Estrogen Receptor Modulators App 20200261428 - Huang; Peter Qinhua ;   et al. | 2020-08-20 |
Estrogen Receptor Modulators App 20200261429 - Huang; Peter Qinhua ;   et al. | 2020-08-20 |
Estrogen Receptor Modulators App 20200261430 - Huang; Peter Qinhua ;   et al. | 2020-08-20 |
Spirocyclic Compounds App 20200207776 - Huang; Peter Qinhua ;   et al. | 2020-07-02 |
Egfr Inhibitor Compounds App 20200181120 - Bunker; Kevin Duane ;   et al. | 2020-06-11 |
Cycloalkyl-linked diheterocycle derivatives Grant 10,676,471 - Burns , et al. | 2020-06-09 |
1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one Analogs App 20200157112 - Huang; Peter Qinhua ;   et al. | 2020-05-21 |
Analgesic compounds Grant 10,653,681 - Bunker , et al. | 2020-05-19 |
Spirocyclic compounds Grant 10,525,036 - Huang , et al. J | 2020-01-07 |
EGFR inhibitor compounds Grant 10,513,509 - Bunker , et al. Dec | 2019-12-24 |
Spirocyclic compounds Grant 10,493,060 - Huang , et al. De | 2019-12-03 |
Cycloalkyl-Linked Diheterocycle Derivatives App 20190270737 - Burns; Aaron Craig ;   et al. | 2019-09-05 |
Bicyclic Compounds App 20190233377 - Bunker; Kevin Duane ;   et al. | 2019-08-01 |
Spirocyclic Compounds App 20190201380 - Huang; Peter Qinhua ;   et al. | 2019-07-04 |
Methods For Cross Coupling App 20190202769 - Pinchman; Joseph Robert ;   et al. | 2019-07-04 |
Estrogen Receptor Modulators App 20190142811 - Huang; Peter Qinhua ;   et al. | 2019-05-16 |
Analgesic Compounds App 20190111031 - Bunker; Kevin Duane ;   et al. | 2019-04-18 |
Analgesic Compounds App 20190099404 - Bunker; Kevin Duane ;   et al. | 2019-04-04 |
Analgesic Compounds App 20190083460 - Bunker; Kevin Duane ;   et al. | 2019-03-21 |
Analgesic Compounds App 20190060257 - Bunker; Kevin Duane ;   et al. | 2019-02-28 |
Cycloalkyl-Linked Diheterocycle Derivatives App 20190040055 - Burns; Aaron Craig ;   et al. | 2019-02-07 |
Cycloalkyl-linked diheterocycle derivatives Grant 10,125,130 - Burns , et al. November 13, 2 | 2018-11-13 |
Spirocyclic Compounds App 20180207132 - Huang; Peter Qinhua ;   et al. | 2018-07-26 |
Bicyclic Compounds App 20180201614 - Bunker; Kevin Duane ;   et al. | 2018-07-19 |
Cycloalkyl-Linked Diheterocycle Derivatives App 20180148441 - BURNS; Aaron Craig ;   et al. | 2018-05-31 |
Egfr Inhibitor Compounds App 20170342055 - Bunker; Kevin Duane ;   et al. | 2017-11-30 |
Cycloalkyl-Linked Diheterocycle Derivatives App 20170050958 - BURNS; Aaron Craig ;   et al. | 2017-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.